ASXSF Elysee Development Corp (PK)

Remedent, Inc. (OTC BB: REMI) a leader in the research and development, manufacturing and marketing of oral care and cosmetic dentistry products, will release a business update and guidance for the remainder of the year and 2007 on Wednesday, October 4, 2006. Management of Remedent will host a conference call the same day at 10 a.m. EDT. The call will include comments about the progress of its business and provide guidance for the next 12-15 months. Those who wish to participate in the call may telephone 888-335-6674, (U.S.), or 973-935-2981, (international callers), passcode #7935948 approximately 15 minutes before the 10 a.m. EST starting time. If you cannot participate in the call, but wish to listen to it, you may login at Remedent�s website at www.remedent.com. You will be able to listen by either Windows Media or Real Player approximately 2 hours after the completion of the call. About Remedent: Remedent, Inc. strives to be a world leader in the research and development, manufacturing and marketing of oral care and cosmetic dentistry products. Remedent products are renowned for their technological superiority and ease-of-use. Based in Deurle, Belgium and El Segundo, CA, Remedent has successfully researched, developed and manufactured all of its own products. These products are now distributed in more than 35 countries worldwide. Remedent consists of two divisions: one that serves the dental community and one that is focused on the over-the-counter consumer market. Visit www.remedent.com for further information. Certain matters discussed in this press release are "forward-looking statements" intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company's statements regarding trends in the marketplace and potential future results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the consummation and the successful integration of proposed acquisitions, the timing of projects due to the variability in size, scope and duration of projects, estimates made by management with respect to the Company's financial results, backlog, critical accounting policies, regulatory delays, clinical study results which lead to reductions or cancellations of projects, and other factors, including general economic conditions and regulatory developments, not within the Company's control. The factors discussed herein and expressed from time to time in the Company's filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed in or implied by such statements. The forward-looking statements are made only as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstance. Remedent, Inc. (OTC BB: REMI) a leader in the research and development, manufacturing and marketing of oral care and cosmetic dentistry products, will release a business update and guidance for the remainder of the year and 2007 on Wednesday, October 4, 2006. Management of Remedent will host a conference call the same day at 10 a.m. EDT. The call will include comments about the progress of its business and provide guidance for the next 12-15 months. Those who wish to participate in the call may telephone 888-335-6674, (U.S.), or 973-935-2981, (international callers), passcode #7935948 approximately 15 minutes before the 10 a.m. EST starting time. If you cannot participate in the call, but wish to listen to it, you may login at Remedent's website at www.remedent.com. You will be able to listen by either Windows Media or Real Player approximately 2 hours after the completion of the call. About Remedent: Remedent, Inc. strives to be a world leader in the research and development, manufacturing and marketing of oral care and cosmetic dentistry products. Remedent products are renowned for their technological superiority and ease-of-use. Based in Deurle, Belgium and El Segundo, CA, Remedent has successfully researched, developed and manufactured all of its own products. These products are now distributed in more than 35 countries worldwide. Remedent consists of two divisions: one that serves the dental community and one that is focused on the over-the-counter consumer market. Visit www.remedent.com for further information. Certain matters discussed in this press release are "forward-looking statements" intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company's statements regarding trends in the marketplace and potential future results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the consummation and the successful integration of proposed acquisitions, the timing of projects due to the variability in size, scope and duration of projects, estimates made by management with respect to the Company's financial results, backlog, critical accounting policies, regulatory delays, clinical study results which lead to reductions or cancellations of projects, and other factors, including general economic conditions and regulatory developments, not within the Company's control. The factors discussed herein and expressed from time to time in the Company's filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed in or implied by such statements. The forward-looking statements are made only as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstance.